Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02179710 · ClinicalTrials.gov registry record
Cystic Fibrosis Treatment Adherence Cayston Proof-of-Concept Pilot Study
A clinical trial, sponsored by Landon Pediatric Foundation.
- Completed
- Registry status
- 18
- Enrollment target
NCT02179710 is a clinical trial that has completed, run by Landon Pediatric Foundation. The registered enrollment target is 18 participants.
The verdict
NCT02179710 has completed, sponsored by Landon Pediatric Foundation.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
Real-world adherence to inhaled and oral therapies for cystic fibrosis (CF) patients remains discouragingly low, ranging between 31-53% for inhaled antibiotics and 41-72% for hypertonic saline. Programs to enhance adherence, including comprehensive behavioral interventions with adolescents, have met with mixed success. Advances in therapy, treatment delivery systems, and data capture technology offer the potential for enhancing adherence by providing immediate and more frequent feedback to the patient regarding his or her fidelity to the prescribed treatment regimen. We propose to conduct a proof-of-concept study to evaluate a systematic approach to linking treatment and feedback components to enhance adherence.
Interventions
- BEHAVIORAL Adherence dashboard motivational interviewing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02179710
The ClinicalTrials.gov registry entry for NCT02179710 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Landon Pediatric Foundation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Adherence dashboard motivational interviewing is the first listed.
NCT02179710 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02179710 about?
NCT02179710 is a clinical study titled "Cystic Fibrosis Treatment Adherence Cayston Proof-of-Concept Pilot Study". Real-world adherence to inhaled and oral therapies for cystic fibrosis (CF) patients remains discouragingly low, ranging between 31-53% for inhaled antibiotics and 41-72% for hypertonic saline. Programs to enhance adherence, including comprehensive behavioral interventions with adolescents, have met...
What is the current status of trial NCT02179710?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2015-03. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02179710?
The interventions under investigation include: Adherence dashboard motivational interviewing (BEHAVIORAL).
Who is sponsoring clinical trial NCT02179710?
This trial is sponsored by Landon Pediatric Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.